Thomas Theo Brehm Selected Research

Thomas Theo Brehm Research Topics

Disease

12	COVID-19 11/2023 - 01/2020
8	Infections 01/2023 - 02/2020
3	Malaria 04/2024 - 01/2020
3	Tuberculosis (Tuberculoses) 04/2024 - 01/2023
3	Human Influenza (Influenza) 11/2022 - 11/2021
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 10/2023 - 07/2023
1	Necrosis 04/2024
1	Epiglottitis 10/2023
1	Latent Tuberculosis 07/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023
1	Dementia (Dementias) 01/2023
1	Hemorrhage 01/2023
1	Disease Progression 01/2023
1	HIV Infections (HIV Infection) 10/2022
1	Reinfection 12/2021
1	Hepatitis A (Hepatitis, Infectious) 01/2021
1	Hepatitis 01/2021
1	Hepatitis E 01/2021
1	Distal Femoral Fractures 02/2020
1	Wound Infection (Wound Infections) 02/2020
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2020
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 07/2019

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 11/2023 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 10/2023
3	COVID-19 VaccinesIBA 08/2022 - 11/2021
3	Peptides (Polypeptides)IBA 01/2022 - 01/2021
2	Antiparasitic Agents (Antiparasitics)IBA 04/2024 - 02/2024
2	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2022
2	sotrovimabIBA 01/2023 - 10/2022
2	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2021
2	AntibodiesIBA 07/2022 - 01/2021
2	NucleoproteinsIBA 01/2022 - 01/2021
1	Janus Kinase InhibitorsIBA 04/2024
1	Tumor Necrosis Factor InhibitorsIBA 04/2024
1	Janus KinasesIBA 04/2024
1	tecovirimatIBA 10/2023
1	Rifampin (Rifampicin)FDA LinkGeneric 07/2023
1	Moxifloxacin (Avelox)FDA Link 07/2023
1	Isoniazid (Ftivazide)FDA LinkGeneric 07/2023
1	rifapentine (Priftin)FDA Link 07/2023
1	Pyrazinamide FDA LinkGeneric 07/2023
1	remdesivirIBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2023
1	Monoclonal AntibodiesIBA 10/2022
1	Viral RNAIBA 10/2022
1	Viral DNAIBA 10/2022
1	imdevimabIBA 10/2022
1	AntigensIBA 07/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Neutralizing AntibodiesIBA 12/2021
1	Oxygen (Dioxygen)IBA 11/2021
1	CreatinineIBA 01/2021
1	BilirubinIBA 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	CytokinesIBA 01/2020
1	Mucin-3IBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 07/2019

Therapy/Procedure

4	Therapeutics 01/2023 - 11/2021
1	Punctures 01/2023
1	Argon Plasma Coagulation 01/2023
1	Length of Stay 10/2022
1	Surgical Amputation (Amputations) 02/2020
1	Debridement 02/2020